Answers are grounded in this paper and cite their sources.
Experimental study demonstrates dual insulin- and epinephrine-driven potassium uptake during severe hypoglycemia, highlighting clinically significant hypokalemia risks.
Counterregulatory secretion of epinephrine occurs during severe insulin-induced hypoglycemia. Under these conditions (minimal plasma glucose 27.4 +/- 1 mg/dl) the decrease of serum potassium concentration (0.9 mVal/L) is mediated by two mechanisms: insulin-induced (0.48 mVal/L) and epinephrine-induced (0.42 mVal/L) cellular uptake of potassium. Epinephrine-induced serum potassium uptake appears to be more sensitive to beta-adrenoceptor blockade than glucose production. The intensification of insulin-induced hypokalemia by epinephrine is of clinical significance.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: